Literature DB >> 2443704

Immunoblot analysis of human IgM, IgG and IgA responses to plasmid-encoded antigens of Yersinia enterocolitica serovar O3.

T H Ståhlberg1, K Granfors, A Toivanen.   

Abstract

Human IgM, IgG and IgA responses after infection with Yersinia enterocolitica serovar O3 were studied by immunoblotting sera against whole-cell homogenates of a plasmid-containing strain of Y. enterocolitica O3 and a plasmid-free strain derived from it; each strain was grown in conditions expressive for the plasmid. The antibodies observed were directed against several plasmid-encoded polypeptides. The response against different bacterial components decreased uniformly with time and the persisting antibody production was directed against several epitopes. Strong reactions to the prominent plasmid-specified antigens of mol. wts (10(3] 26, 34, 45 and 52.5 were found more often with IgG-class antibodies than with IgM or IgA; the latter immunoglobulins recognised, respectively, antigens of mol. wt (10(3] 26 and 45 (IgM) and 26, 34 and 52.5 (IgA). Immunoblotting of sera from patients with yersinia-triggered reactive arthritis did not reveal any antigens that were involved additionally or specifically. However, IgA-mediated recognition of certain antigens of mol. wts (10(3] 26, 34 and 52.5 tended to persist longer in the arthritic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443704     DOI: 10.1099/00222615-24-2-157

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

1.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis.

Authors:  N Tsuchiya; G Husby; R C Williams
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Comparison of bacteria with and without plasmid-encoded proteins as antigens for measurement of immunoglobulin M, G, and A antibodies to Yersinia enterocolitica by enzyme-linked immunosorbent assay.

Authors:  K Granfors; R Lahesmaa-Rantala; T H Ståhlberg; A Toivanen
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

Review 4.  Immunological and bacteriological aspects of reactive arthritis.

Authors:  A Toivanen; K Granfors; R Lahesmaa-Rantala; P Toivanen
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

5.  Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis.

Authors:  T H Ståhlberg; J Heesemann; K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

6.  Evaluation of a western blot method for the detection of Yersinia antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi.

Authors:  Mindy L Rawlins; Cecilia Gerstner; Harry R Hill; Christine M Litwin
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

7.  Avidity of antibodies against released proteins of Yersinia spp: comparison of patients with or without reactive arthritis.

Authors:  R Lahesmaa-Rantala; J Heesemann; O P Lehtonen; K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

8.  Humoral immune response to individual Yersinia enterocolitica antigens in patients with and without reactive arthritis.

Authors:  A Grönberg; A Frydén; E Kihlström
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

9.  Yersinia lipopolysaccharide is modified by human monocytes.

Authors:  M Wuorela; S Jalkanen; P Toivanen; K Granfors
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 10.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.